Production of the effector cytokine interleukin-17, rather than interferon-γ, is more strongly associated with autoimmune hemolytic anemia

Haematologica

Volumn 97, Issue 10, 2012, Pages 1494-1500

  Hall, Andrew M ^a   Zamzami, Omar M ^a   Whibley, Natasha ^a   Hampsey, Daniel P ^a   Haggart, Anne M ^a   Vickers, Mark A ^a,b   Barker, Robert N ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Autoimmune hemolytic anemia; Autoimmunity; Interferon ; Interleukin 17; T lymphocyte

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE;

ADULT; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOANTIGENS; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; EPITOPES; ERYTHROCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 84867265067     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.060822     Document Type: Article

References (53)

1. Williams RO, Paleolog E, Feldmann M. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol. 2007;7(4):412-7.
2. Noti M, Corazza N, Mueller C, Berger B, Brunner T. TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis. J Exp Med. 2010;207(5): 1057-66.
3. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 1995;16(1):34-8.
4. Petz LD, Garratty G. Immune hemolytic anemias. Second edition ed.: Churchill Livingstone; 2003.
5. Barker RN, Vickers MA, Ward FJ. Controlling autoimmunity - Lessons from the study of red blood cells as model antigens. Immunol Lett. 2007;108(1):20-6.
6. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163-89.
7. Kelsoe G. The germinal center reaction. Immunol Today. 1995;16(7):324-6.
8. Elson CJ, Barker RN. Helper T cells in antibody- mediated, organ-specific autoimmunity. Curr Opin Immunol. 2000;12(6):664-9.
9. Oliveira GG, Hutchings PR, Roitt IM, Lydyard PM. Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies. Clin Exp Immunol. 1994;96(2):297-302.
10. Chen SY, Takeoka Y, Ansari AA, Boyd R, Klinman DM, Gershwin ME. The natural history of disease expression in CD4 and CD8 gene-deleted New Zealand black (NZB) mice. J Immunol. 1996;157(6):2676-84.
11. Shen CR, Youssef AR, Devine A, Bowie L, Hall AM, Wraith DC, et al. Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia. Blood. 2003;102(10): 3800-6.
12. Barker RN, Casswell KM, Reid ME, Sokol RJ, Elson CJ. Identification of autoantigens in autoimmune haemolytic anaemia by a nonradioisotope immunoprecipitation method. Br J Haematol. 1992;82(1):126-32.
13. Leddy JP, Falany JL, Kissel GE, Passador ST, Rosenfeld SI. Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies. J Clin Invest. 1993;91(4):1672-80.
14. Barker RN, Hall AM, Standen GR, Jones J, Elson CJ. Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia. Blood. 1997;90(7):2701-15.
15. Barker RN, Elson CJ. Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells in vitro. Eur J Immunol. 1994;24(7):1578-82.
16. Elson CJ, Barker RN, Thompson SJ, Williams NA. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today. 1995;16(2):71-6.
17. Hall AM, Vickers MA, McLeod E, Barker RN. Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. Blood. 2005;105(5):2007-15.
18. Mittal S, Blaylock MG, Culligan DJ, Barker RN, Vickers MA. A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura. Haematologica. 2008;93(1):151-2.
19. Hall AM, Ward FJ, Vickers MA, Stott LM, Urbaniak SJ, Barker RN. Interleukin-10- mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood. 2002;100(13):4529-36.
20. Shen CR, Mazza G, Perry FE, Beech JT, Thompson SJ, Corato A, et al. T-helper 1 dominated responses to erythrocyte Band 3 in NZB mice. Immunology. 1996;89(2):195-9.
21. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136(7):2348-57.
22. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111-47.
23. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821-52.
24. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006;18(3):349-56.
25. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol. 1996;156(1):5-7.
26. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(1):1-11.
27. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol. 2006;177(1):566-73.
28. Cartron JP, Rouillac C, Le Van Kim C, Mouro I, Colin Y. Tentative model for the mapping of D epitopes on the RhD polypeptide. Transfus Clin Biol. 1996;3(6):497-503.
29. Arce MA, Thompson ES, Wagner S, Coyne KE, Ferdman BA, Lublin DM. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood. 1993;82(2):651-5.
30. Hooper DC, Young JL, Elson CJ, Taylor RB. Murine T cells reactive against autologous erythrocytes: evidence for in vitro and in vivo priming with mouse and rat red blood cells. Cell Immunol. 1987;106(1):53-61.
31. Barker RN, Shen CR, Elson CJ. T-cell specificity in murine autoimmune haemolytic anaemia induced by rat red blood cells. Clin Exp Immunol. 2002;129(2):208-13.
32. Barker RN, Elson CJ. Red blood cell glycophorins as B and T-cell antigens in canine autoimmune haemolytic anaemia. Vet Immunol Immunopathol. 1995;47(3-4):225-38.
33. Devereux G, Hall AM, Barker RN. Measurement of T-helper cytokines secreted by cord blood mononuclear cells in response to allergens. J Immunol Methods. 2000;234(1-2):13-22.
34. Barker RN, Gruffydd-Jones TJ, Stokes CR, Elson CJ. Autoimmune haemolysis in the dog: relationship between anaemia and the levels of red blood cell bound immunoglobulins and complement measured by an enzyme-linked antiglobulin test. Vet Immunol Immunopathol. 1992;34(1-2):1-20.
35. Sokol RJ, Booker DJ, Stamps R. The pathology of autoimmune haemolytic anaemia. J Clin Pathol. 1992;45(12):1047-52.
36. Barker RN, Young RD, Leader KA, Elson CJ. Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia. Clin Exp Immunol. 1999;117(3):449-54.
37. Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, Kolls JK, et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA. 2010;107(32):14292-7.
38. Youssef AR, Shen CR, Lin CL, Barker RN, Elson CJ. IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice. Clin Exp Immunol. 2005;139(1):84-9.
39. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87-113.
40. Hoyer KK, Kuswanto WF, Gallo E, Abbas AK. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood. 2009;113(2):389-95.
41. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM. Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun. 2011;36(1):65-75.
42. Yuan J, Cao AL, Yu M, Lin QW, Yu X, Zhang JH, et al. Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis. J Clin Immunol. 2010;30(2):226-34.
43. Rocha AM, Souza C, Rocha GA, de Melo FF, Clementino NC, Marino MC, et al. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica. 2011;96(10):1560-4.
44. Zhang J, Ma D, Zhu X, Qu X, Ji C, Hou M. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009;94(9):1326-9.
45. Izui S, Fossati-Jimack L, da Silveira SA, Moll T. Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia. Springer Semin Immunopathol. 2001;23(4):433-45.
46. Stott LM, Barker RN, Urbaniak SJ. Identification of alloreactive T-cell epitopes on the Rhesus D protein. Blood. 2000;96 (13):4011-9.
47. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol. 1997;15: 821-50.
48. Cairns LS, Phelps RG, Bowie L, Hall AM, Saweirs WW, Rees AJ, et al. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol. 2003;14(11):2801-12.
49. Quinn A, McInerney B, Reich EP, Kim O, Jensen KP, Sercarz EE. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. J Immunol. 2001;166(5):2982-91.
50. Hall AM, Vickers MA, Barker RN, Erwig LP. Helper T cells point the way to specific immunotherapy for autoimmune disease. Cardiovasc Hematol Disord Drug Targets. 2009;9(3):159-66.
51. Kimball AB, Gordon KB, Langley RG, Menter A, Chartash EK, Valdes J, et al. Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch Dermatol. 2008;144(2):200-7.
52. Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, et al. Efficacy and safety of ustekinumab, a human interleukin- 12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet. 2008;371(9625): 1665-74.
53. Sabatos-Peyton CA, Verhagen J, Wraith DC. Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr Opin Immunol. 2010;22(5):609-15.